Sivifene, formerly known as A-007, is a immunomodulating agent with potential antineoplastic activities. Sivifene may stimulate a local immune response against human papillomavirus (HPV)-induced cervical intraepithelial neoplasia (CIN). A-007 possesses three moieties that appear to have an influence on its diphenylmethane, hydrazone, and dinitrophenyl. A-007, as a 0.25% gel, is confirmed as an effective palliative treatment option for cutaneous metastases from cancers. References: Sagiraju S, Chen K, Cole RB, Jursic BS. Electrospray-ionization mass spectrometry study of cyclodextrin complexes with A007 prodrugs. Carbohydr Res. 2009 Nov 2;344(16):2167-72. doi: 10.1016/j.carres.2009.06.042. Epub 2009 Jul 22. PubMed PMID: 19729153.

纯度：≥98%

CAS：2675-35-6